Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population

Intensive research is carried out to develop a disease-modifying drug for Alzheimer’s disease (AD). The development of drug candidates that reduce Aß or tau in the brain seems particularly promising. However, these drugs target people at risk for AD, who must be identified before they have any, or o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustavsson, Erik, Raaschou, Pauline, Lärfars, Gerd, Sandman, Lars, Juth, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Feature Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394767/
https://www.ncbi.nlm.nih.gov/pubmed/34117127
http://dx.doi.org/10.1136/medethics-2021-107304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394767/
https://www.ncbi.nlm.nih.gov/pubmed/34117127
http://dx.doi.org/10.1136/medethics-2021-107304

Ejemplares similares